Skip to main content

Advertisement

SpringerLink
Log in

Dual-pathway inhibition in patients with chronic limb-threatening ischemia requiring reintervention for infrapopliteal occlusions

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Our study aimed to assess the influence of incorporating new oral anticoagulant (NOAC) therapy on clinical outcomes among patients who underwent endovascular intervention for below-the-knee (BTK) occlusions necessitating reintervention. The inclusion criteria encompassed patients with chronic limb-threatening ischemia (CLTI) and had undergone a successful endovascular intervention for BTK artery occlusion, necessitating reintervention. Patients who underwent endovascular interventions for BTK reocclusion were compared to those who received dual-pathway inhibition with NOAC (rivaroxaban 2.5 mg 2 × 1) and clopidogrel (NOAC group), or dual-antiplatelet therapy with clopidogrel and aspirin (DAPT group). The primary endpoints were target vessel reocclusion and target lesion revascularization (TLR) at the 1-year follow-up, while major and minor amputations served as the secondary endpoint. Additionally, a one-year comparison was conducted between the two groups for major bleeding events. 64 patients in our clinic treated with endovascular reintervention (NOAC = 28, DAPT = 34). The TLR rate is 10.7% in NOAC group (N = 3) and 32.4% in DAPT group (N = 11, p = 0.043). The target vessel reocclusion rate is 17.8% in NOAC group (N = 5) and 41.2% in DAPT group (N = 14, p = 0.048). Minor or major amputation rate at 1-year follow-up was 3.6% in NOAC group (N = 1) and 11.7% in DAPT group (N = 4, p = 0.245). The patency rate is significantly higher, and the TLR rate is significantly lower in the NOAC group compared to the DAPT group, with no significant difference in major bleeding between the two groups. Although no statistically significant difference exists in amputation rates, a numerical distinction is evident.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data used in this study are available from the hospital archive and my personal archive.

References

  1. Wu H, Zheng D, Zhou L, Wang Q, Wang T, Liang S (2023) A systematic review and meta-analysis of atherectomy plus balloon angioplasty versus balloon angioplasty alone for infrapopliteal arterial disease. J Endovasc Ther 7:15266028231209236. https://doi.org/10.1177/15266028231209236

    Article  Google Scholar 

  2. Barbarawi M, Qazi AH, Lee J, Barbarawi O, Al-Abdouh A, Mhanna M, Vashist A (2022) Meta-analysis comparing drug-coated balloons and percutaneous transluminal angioplasty for infrapopliteal artery disease. Am J Cardiol 183:115–121

    Article  PubMed  Google Scholar 

  3. Giannopoulos S, Armstrong EJ (2022) Intravascular lithotripsy for optimal angioplasty of infrapopliteal calcified lesions. J Invasive Cardiol E132–E141

  4. Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2014) 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 35:2541–2619

    Article  Google Scholar 

  5. Eikelboom JW, Bosch J, Connolly SJ, Tyrwitt J, Fox KAA, Muehlhofer E, Neumann C, Tasto C, Bangdiwala SI, Diaz R, Alings M, Dagenais GR, Leong DP, Lonn EM, Avezum A, Piegas LS, Widimsky P, Parkhomenko AN, Bhatt DL, Branch KRH, Probstfield JL, Lopez-Jaramillo P, Rydén L, Pogosova N, Keltai K, Keltai M, Ertl G, Stoerk S, Dans AL, Lanas F, Liang Y, Zhu J, Torp-Pedersen C, Maggioni AP, Commerford PJ, Guzik TJ, Vanassche T, Verhamme P, O’Donnell M, Tonkin AM, Varigos JD, Vinereanu D, Felix C, Kim JH, Ibrahim KS, Lewis BS, Metsarinne KP, Aboyans V, Steg PG, Hori M, Kakkar A, Anand SS, Lamy A, Sharma M, Yusuf S (2022) Long-term treatment with the combination of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: outcomes during the open label extension of the COMPASS trial. Eur Heart J Cardiovasc Pharmacother 8(8):786–795

    Article  PubMed  Google Scholar 

  6. Moll F, Baumgartner I, Jaff M, Nwachuku C, Tangelder M, Ansel G, Adams G, Zeller T, Rundback J, Grosso M, Lin M, Mercur MF, Minar E, ePAD Investigators (2018) Edoxaban plus aspirin vs dual antiplatelet therapy in endovascular treatment of patients with peripheral artery disease: results of the ePAD trial. J Endovasc Ther 2:158–168

    Article  Google Scholar 

  7. Bauersachs RM, Szarek M, Brodmann M, Gudz I, Debus ES, Nehler MR, Anand SS, Patel MR, Hess CN, Capell WH, Rogers K, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR, Bonaca MP, VOYAGERPAD Committees and Investigators (2021) Total ischemic event reduction with rivaroxaban after peripheral arterial revascularization in the VOYAGER PAD trial. J Am Coll Cardiol 78(4):317–326

    Article  CAS  PubMed  Google Scholar 

  8. Chen X, Huang W, Sun A, Wang L, Mo F, Guo W (2021) Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis. Thromb J 19(1):69

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Paraskevopoulos I, Karnabatidis D (2020) Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials. J Vasc Interv Radiol 2:202–212

    Article  Google Scholar 

  10. Mustapha JA, Brodmann M, Geraghty PJ, Saab F, Settlage RA, Jaff MR (2019) Lutonix BTK study investigators. drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: six-month results of the lutonix BTK trial. J Invasive Cardiol 8:205–211

    Google Scholar 

  11. Böhme T, Beschorner U, Noory E, Molitor M, Nührenberg T, Neumann FJ, Zeller T (2022) Effect of paclitaxel drug-coated balloon angioplasty of infrapopliteal lesions on mortality. Tex Heart Inst J 49(6):e217560

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zeller T, Micari A, Scheinert D, Baumgartner I, Bosiers M, Vermassen FEG, Banyai M, Shishehbor MH, Wang H, Brodmann M, IN.PACT DEEP Trial Investigators (2020) The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes. JACC Cardiovasc Interv 13(4):431–443

    Article  PubMed  Google Scholar 

  13. Lee MS, Mustapha J, Beasley R, Chopra P, Das T, Adams GL (2016) Impact of lesion location on procedural and acute angiographic outcomes in patients with critical limb ischemia treated for peripheral artery disease with orbital atherectomy: a CONFIRM registries subanalysis. Catheter Cardiovasc Interv 87(3):440–445

    Article  PubMed  Google Scholar 

  14. Giusca S, Lichtenberg M, Schueler M, Heinrich U, Eisenbach C, Andrassy M, Korosoglou G (2021) Safety, effectiveness and mid-term follow-up in 136 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy. Heart Vessels 36(3):366–375

    Article  PubMed  Google Scholar 

  15. Giusca S, Hagstotz S, Lichtenberg M, Heinrich U, Eisenbach C, Andrassy M, Korosoglou G (2022) Phoenix atherectomy for patients with peripheral artery disease. EuroIntervention 18(5)

  16. Adams G, Soukas PA, Mehrle A, Bertolet B, Armstrong EJ (2022) Intravascular lithotripsy for treatment of calcified infrapopliteal lesions: results from the disrupt PAD III observational study. J Endovasc Ther 29(1):76–83

    Article  PubMed  Google Scholar 

  17. Kuku KO, Garcia-Garcia HM, Finizio M, Melaku GD, Wilson VA, Beyene SS, Kahsay Y, Jones-McMeans JM, Rapoza RJ, Parikh SA, DeRubertis BG, Varcoe RL, Adams GL (2022) Comparison of angiographic and intravascular ultrasound vessel measurements in infra-popliteal endovascular interventions: the below-the-knee calibration study. Cardiovasc Revasc Med 35:35–41

    Article  PubMed  Google Scholar 

  18. Scheinert D, Katsanos K, Zeller T, Koppensteiner R, Commeau P, Bosiers M, Krankenberg H, Baumgartner I, Siablis D, Lammer J, Van Ransbeeck M, Qureshi AC, Stoll HP, ACHILLES Investigators (2012) A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol 60:2290–2295

    Article  PubMed  Google Scholar 

  19. Rastan A, Brechtel K, Krankenberg H, Zahorsky R, Tepe G, Noory E, Schwarzwälder U, Macharzina R, Schwarz T, Bürgelin K, Sixt S, Tübler T, Neumann FJ, Zeller T (2012) Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol 60:587–591

    Article  CAS  PubMed  Google Scholar 

  20. Matsuoka EK, Hasebe T, Ishii R, Miyazaki N, Soejima K, Iwasaki K (2022) Comparative performance analysis of interventional devices for the treatment of ischemic disease in below-the-knee lesions: a systematic review and meta-analysis. Cardiovasc Interv Ther 37(1):145–157

    Article  CAS  PubMed  Google Scholar 

  21. Adams GL, Lichtenberg M, Wissgott C, Schmidt A, Tarra T, Matricardi S, Geraghty PJ (2023) Twenty-four month results of tack-optimized balloon angioplasty using the tack endovascular system in below-the-knee arteries. J Endovasc Ther 30(3):393–400

    Article  PubMed  Google Scholar 

  22. Varcoe RL, DeRubertis BG, Kolluri R, Krishnan P, Metzger DC, Bonaca MP, Shishehbor MH, Holden AH, Bajakian DR, Garcia LA, Kum SWC, Rundback J, Armstrong E, Lee JK, Khatib Y, Weinberg I, Garcia-Garcia HM, Ruster K, Teraphongphom NT, Zheng Y, Wang J, Jones-McMeans JM, Parikh SA, LIFE-BTK Investigators (2024) Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease. N Engl J Med 390(1):9–19

    Article  CAS  PubMed  Google Scholar 

  23. Aoyama N, Nishinari M, Ohtani S, Kanai A, Noda C, Hirata M, Miyamoto A, Watanabe M, Minamino T, Izumi T, Ako J (2017) Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis. Heart Vessels 32(9):1099–1108

    Article  PubMed  Google Scholar 

  24. Chioncel V, Brezeanu R, Sinescu C (2019) New directions in the management of peripheral artery disease. Am J Ther 26(2):e284–e293

    Article  PubMed  Google Scholar 

  25. Spiliopoulos S, Davoutis E, Arkoudis NA, Sritharan K, Lechareas S (2023) Percutaneous deep venous arterialization for limb salvage in no option patients with chronic limb-threatening ischemia. J Clin Med 12(23):7324

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

No grant received.

Author information

Authors and Affiliations

  1. Department of Cardiology, Emsey Hospital, Kurtköy Pendik, 34912, Istanbul, Turkey

    Burak Teymen

  2. Department of Cardiovascular Surgery, Emsey Hospital, Istanbul, Turkey

    Mehmet Emin Öner

  3. Department of Orthopaedics and Traumatology, Medar Hospital, Kocaeli, Turkey

    Yiğit Erdağ

Authors
  1. Burak Teymen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Emin Öner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yiğit Erdağ
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Burak Teymen.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teymen, B., Öner, M.E. & Erdağ, Y. Dual-pathway inhibition in patients with chronic limb-threatening ischemia requiring reintervention for infrapopliteal occlusions. Heart Vessels (2024). https://doi.org/10.1007/s00380-024-02406-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00380-024-02406-5

Keywords

Search

Navigation